ChrysCapital-led consortium acquires 70.68 percent stake in Novartis India
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ChrysCapital Fund X, WaveRise Investments and Two Infinity Partners acquired about 70.68 percent of Novartis India through off-market transfer on July 29, 2026. ChrysCapital Fund X bought 56.45 percent, WaveRise bought 10.32 percent and Two Infinity bought 3.91 percent. Post acquisition, the acquirers have become promoters and taken control of the company, marking a change of control from the existing promoter.
Major change of control as ChrysCapital consortium takes over about 70 percent stake. New promoters appointed, strategy may shift.